Possible Mechanism of Interleukin-2-Induced Decline of Serum Cholesterol During Adoptive Cellular Immunotherapy in Cancer Patients
Biochemical Medicine and Metabolic Biology · 1993
DOI: 10.1006/bmmb.1993.1023 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biochemical Medicine and Metabolic Biology, 1993. Verfasst von N Swaminathan und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, City of Hope Medical Center, Duarte, California 91010. Hauptthemen laut MEDLINE: Immunotherapy, Adoptive. Die Arbeit wurde bisher 4-mal zitiert (Crossref).
Themen: Onkologische Pflege
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Cardiology, City of Hope Medical Center, Duarte, California 91010.
Zitieren
APA
Swaminathan, N., Venkataraman, K., Gadgil, U., & Margolin, K. (1993). Possible Mechanism of Interleukin-2-Induced Decline of Serum Cholesterol During Adoptive Cellular Immunotherapy in Cancer Patients. Biochemical Medicine and Metabolic Biology. https://doi.org/10.1006/bmmb.1993.1023
Vancouver
Swaminathan N, Venkataraman K, Gadgil U, Margolin K. Possible Mechanism of Interleukin-2-Induced Decline of Serum Cholesterol During Adoptive Cellular Immunotherapy in Cancer Patients. Biochemical Medicine and Metabolic Biology. 1993. doi:10.1006/bmmb.1993.1023
BibTeX
@article{Swaminathan1993,
author = {Swaminathan, N and Venkataraman, K and Gadgil, U and Margolin, K},
title = {Possible Mechanism of Interleukin-2-Induced Decline of Serum Cholesterol During Adoptive Cellular Immunotherapy in Cancer Patients},
journal = {Biochemical Medicine and Metabolic Biology},
year = {1993},
doi = {10.1006/bmmb.1993.1023}
}
EUVIMED